| Accession |
PRJCA011551 |
| Title |
An open, single-arm, multicenter phase I trial of the safety, tolerability, pharmacokinetics, and efficacy of SHR-A1904 for injection in patients with advanced solid tumors |
| Relevance |
Medical |
| Data types |
Clinical metabolic imaging biomarker gene data
|
| Organisms |
Homo sapiens
|
| Description |
An open, single-arm, multicenter phase I trial of the safety, tolerability, pharmacokinetics, and efficacy of SHR-A1904 for injection in patients with advanced solid tumors |
| Sample scope |
Multiisolate |
| Release date |
2022-09-01 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Shanghai Hengrui Pharmaceutical Co., LTD
|
NA
|
NA
|
NA
|
|
|
| Submitter |
Jia
Ao
Pan (jiaao.pan@hengrui.com)
|
| Organization |
Jiangsu Hengrui Pharmaceutical Co. LTD |
| Submission date |
2022-08-30 |
